coin-img-ETHETH-0.05%coin-img-SOLSOL+0.01%coin-img-BTCBTC+1.38%coin-img-USDCUSDC-0.01%coin-img-XRPXRP-0.80%coin-img-HYPEHYPE+1.12%coin-img-TRXTRX-0.27%coin-img-BNBBNB-0.13%coin-img-ETHETH-0.05%coin-img-SOLSOL+0.01%coin-img-BTCBTC+1.38%coin-img-USDCUSDC-0.01%coin-img-XRPXRP-0.80%coin-img-HYPEHYPE+1.12%coin-img-TRXTRX-0.27%coin-img-BNBBNB-0.13%coin-img-ETHETH-0.05%coin-img-SOLSOL+0.01%coin-img-BTCBTC+1.38%coin-img-USDCUSDC-0.01%coin-img-XRPXRP-0.80%coin-img-HYPEHYPE+1.12%coin-img-TRXTRX-0.27%coin-img-BNBBNB-0.13%coin-img-ETHETH-0.05%coin-img-SOLSOL+0.01%coin-img-BTCBTC+1.38%coin-img-USDCUSDC-0.01%coin-img-XRPXRP-0.80%coin-img-HYPEHYPE+1.12%coin-img-TRXTRX-0.27%coin-img-BNBBNB-0.13%
user-avatar
The Motley Fool Australia

Pro Medicus posts FY26 revenue of A$261.7 million and lifts dividend 25.5% to 69 cents per share

AI Market Summary
Pro Medicus reported strong FY revenue and underlying earnings growth, maintained a debt-free balance sheet, increased cash, and raised its fully franked dividend. Contract wins and renewals expand multi-year revenue visibility, while constant-currency growth and an improving pipeline suggest resilient demand. The update is supportive for Australian healthcare/tech sentiment, though broader cross-asset impact is likely limited.
Impact level
● Low
Affected assets
NCCOGOLD2USD/USDT+0.08%
AI Insight · NCCOGOLD2USD/USDTAI Insight
▲ Bullish
Trade now
⚠️ AI-generated insights are based on news content and are provided for informational purposes only. They do not constitute investment advice or represent the views of BingX. Investing involves risk. Please trade responsibly.
Pro Medicus reported full-year revenue of A$261.7 million, up 22.9% year on year, with underlying NPAT rising 24.1% to A$144.7 million. The company remained debt-free as cash and financial assets increased to A$252.3 million. It lifted its full-year dividend by 25.5% to 69 cents per share. During the year, it signed 10 new contracts worth at least A$407 million, including a 10-year deal with UC Health Colorado.
Disclaimer: The content above is only the author's opinion and does not represent BingX’s stance. It shall not be construed as investment advice from BingX. For details, refer to the Terms and Conditions.
Stocks

Risk Warning

Cryptocurrencies and their derivatives are innovative financial products with great volatility and high investment risks.

Although BingX is committed to providing users with easy-to-use trading tools, trading itself is still a highly sophisticated field. Trading digital assets and their derivatives are subject to high market risk and price volatility and may result in partial or total loss of account funds. You must carefully consider and exercise clear judgment to evaluate your financial situation and the aforementioned risks before using BingX Services. You shall be responsible for all losses arising therefrom. If necessary, please consult relevant professionals to make informed decisions before investing. By accessing, downloading, using or clicking on "I agree" to accept any BingX Services provided by BingX, you agree that you have read, understood and accepted all of the terms and conditions stipulated in BingX Terms of Use as well as our Privacy Policy.


Trading by copying or replicating the trades of other traders involves a high level of risks, even when copying or replicating the top-performing traders. Past performance of a BingX community member is not a reliable indicator of his future performance. Content on BingX's trading platform is generated by members of its community and does not contain advice or recommendations by or on behalf of BingX.